rs145758265

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_031407.7(HUWE1):​c.3082A>G​(p.Thr1028Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000751 in 1,207,806 control chromosomes in the GnomAD database, including 2 homozygotes. There are 309 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00074 ( 0 hom., 24 hem., cov: 23)
Exomes š‘“: 0.00075 ( 2 hom. 285 hem. )

Consequence

HUWE1
NM_031407.7 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 2.44

Publications

5 publications found
Variant links:
Genes affected
HUWE1 (HGNC:30892): (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) This gene encodes a protein containing a C-terminal HECT (E6AP type E3 ubiquitin protein ligase) domain that functions as an E3 ubiquitin ligase. The encoded protein is required for the ubiquitination and subsequent degradation of the anti-apoptotic protein Mcl1 (myeloid cell leukemia sequence 1 (BCL2-related)). This protein also ubiquitinates the p53 tumor suppressor, core histones, and DNA polymerase beta. Mutations in this gene are associated with Turner type X-linked syndromic cognitive disability. [provided by RefSeq, Aug 2013]
HUWE1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked syndromic, Turner type
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046494603).
BP6
Variant X-53600199-T-C is Benign according to our data. Variant chrX-53600199-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 196188.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00074 (83/112210) while in subpopulation NFE AF = 0.00117 (62/53171). AF 95% confidence interval is 0.000934. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 83 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HUWE1NM_031407.7 linkc.3082A>G p.Thr1028Ala missense_variant Exon 29 of 84 ENST00000262854.11 NP_113584.3 Q7Z6Z7-1A0A024R9W5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HUWE1ENST00000262854.11 linkc.3082A>G p.Thr1028Ala missense_variant Exon 29 of 84 1 NM_031407.7 ENSP00000262854.6 Q7Z6Z7-1

Frequencies

GnomAD3 genomes
AF:
0.000740
AC:
83
AN:
112157
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00309
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00117
Gnomad OTH
AF:
0.000662
GnomAD2 exomes
AF:
0.000960
AC:
176
AN:
183253
AF XY:
0.000945
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.0000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00463
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.000884
GnomAD4 exome
AF:
0.000752
AC:
824
AN:
1095596
Hom.:
2
Cov.:
30
AF XY:
0.000789
AC XY:
285
AN XY:
360990
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26358
American (AMR)
AF:
0.0000568
AC:
2
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19363
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30193
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54066
European-Finnish (FIN)
AF:
0.00540
AC:
219
AN:
40528
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4130
European-Non Finnish (NFE)
AF:
0.000672
AC:
564
AN:
839754
Other (OTH)
AF:
0.000826
AC:
38
AN:
46006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000740
AC:
83
AN:
112210
Hom.:
0
Cov.:
23
AF XY:
0.000698
AC XY:
24
AN XY:
34364
show subpopulations
African (AFR)
AF:
0.0000324
AC:
1
AN:
30898
American (AMR)
AF:
0.00
AC:
0
AN:
10679
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2692
European-Finnish (FIN)
AF:
0.00309
AC:
19
AN:
6139
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00117
AC:
62
AN:
53171
Other (OTH)
AF:
0.000654
AC:
1
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00105
Hom.:
48
Bravo
AF:
0.000400
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00104
AC:
7
ExAC
AF:
0.00134
AC:
163
EpiCase
AF:
0.000600
EpiControl
AF:
0.000771

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 02, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24307393) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Jun 01, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 28, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

HUWE1-related disorder Benign:1
Apr 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
19
DANN
Benign
0.84
DEOGEN2
Benign
0.26
.;T;T
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.80
T;.;T
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.0046
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;N;N
PhyloP100
2.4
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.47
.;N;N
REVEL
Benign
0.052
Sift
Benign
0.73
.;T;T
Sift4G
Benign
0.75
T;T;T
Polyphen
0.0
.;B;B
Vest4
0.075
MVP
0.44
MPC
0.92
ClinPred
0.0091
T
GERP RS
4.1
Varity_R
0.050
gMVP
0.19
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145758265; hg19: chrX-53627159; COSMIC: COSV106089600; API